| Health / Medical Topics |
PARP inhibitor AZD2281
Pronunciation
A substance being studied in the treatment of breast, ovarian, and prostate cancers caused by mutations (changes) in the BRCA1 and BRCA2 genes. It is also being studied in the treatment of other types of cancer. It blocks an enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may be caused by normal cell actions, UV light, some anticancer drugs, and radiation used to treat cancer. PARP inhibitor AZD2281 may cause cancer cells to die. It is a type of targeted therapy agent and a type of poly (ADP-ribose) polymerase inhibitor. Also called AZD2281 and olaparib. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance that blocks an enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may…
An orally available small molecule inhibitor of the nuclear enzymes poly (ADP-ribose) polymerase (PARP) 1 and 2, with potential antineoplastic activity. Upon…
A type of enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may be caused…
An episodic form of ventricular tachycardia, with abrupt onset and termination.
An electrocardiographic finding of episodic tachycardia with abrupt onset and termination.
An electrocardiographic finding of episodic supraventricular tachycardia with abrupt onset and termination.
